Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis

Medicine & Life Sciences

1. Gene Fusion 100%
2. Prostatic Neoplasms 63%
3. p53 Genes 58%
4. Genes 39%
5. Neoplasms 37%
6. Demethylation 21%
7. Phosphorylation 18%
8. Chromatin 15%
9. Cell Cycle 13%
10. Prostatic Intraepithelial Neoplasia 12%
11. Cyclin-Dependent Kinase 2 12%
12. Sequence Deletion 10%
13. Second Primary Neoplasms 10%
14. Threonine 9%
15. Gene Deletion 9%
16. Preliminary Data 9%
17. Transgenes 8%
18. Oncogenes 8%
19. Transcriptome 8%
20. Androgens 8%
21. Epigenomics 7%
22. Prostate 7%
23. Inpatients 7%
24. Cause of Death 7%
25. Down-Regulation 6%
26. Gene Expression 5%